Specific considerations include: Beta blockers (metoprolol, atenolol, propranolol) lower heart rate by blocking sympathetic stimulation
Some men use an ongoing care plan that includes meds, labs, and follow-ups
Wegovy is a prescription medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities, as per NICE Technology Appraisal 875
Participants have reported visible improvements in hair thickness, density, and overall health within just a few months of consistent use
A expectativa que os primeiros resultados sejam divulgados a partir de setembro de 2025, com a concluso dos estudos prevista para 2026